TR200400313T3 - Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler - Google Patents

Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler

Info

Publication number
TR200400313T3
TR200400313T3 TR200400313T TR200400313T TR200400313T3 TR 200400313 T3 TR200400313 T3 TR 200400313T3 TR 200400313 T TR200400313 T TR 200400313T TR 200400313 T TR200400313 T TR 200400313T TR 200400313 T3 TR200400313 T3 TR 200400313T3
Authority
TR
Turkey
Prior art keywords
forms
oxcarbazepine
processes
preparation
new crystal
Prior art date
Application number
TR200400313T
Other languages
English (en)
Turkish (tr)
Inventor
Judith Aronhime
Ben-Zion Dolitzky
Yana Berkovich
Nissim Garth
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of TR200400313T3 publication Critical patent/TR200400313T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
TR200400313T 2001-02-12 2002-02-12 Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler TR200400313T3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26831401P 2001-02-12 2001-02-12

Publications (1)

Publication Number Publication Date
TR200400313T3 true TR200400313T3 (tr) 2004-04-21

Family

ID=23022405

Family Applications (1)

Application Number Title Priority Date Filing Date
TR200400313T TR200400313T3 (tr) 2001-02-12 2002-02-12 Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler

Country Status (11)

Country Link
US (1) US7183272B2 (cg-RX-API-DMAC7.html)
EP (1) EP1368322A4 (cg-RX-API-DMAC7.html)
JP (1) JP2004526706A (cg-RX-API-DMAC7.html)
AU (1) AU2002250057A1 (cg-RX-API-DMAC7.html)
CA (1) CA2437402A1 (cg-RX-API-DMAC7.html)
DE (1) DE02718948T1 (cg-RX-API-DMAC7.html)
ES (1) ES2211373T1 (cg-RX-API-DMAC7.html)
HU (1) HUP0303154A3 (cg-RX-API-DMAC7.html)
IL (1) IL157351A0 (cg-RX-API-DMAC7.html)
TR (1) TR200400313T3 (cg-RX-API-DMAC7.html)
WO (1) WO2002064557A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US20060166968A1 (en) * 2004-07-16 2006-07-27 Sundaram Venkataraman Crystalline form of oxcarbazepine
EP1828098A1 (en) * 2005-11-22 2007-09-05 Teva Pharmaceutical Industries Ltd Crystal forms of cinacalcet hci and processes for their preparation
TWI363058B (en) * 2006-04-05 2012-05-01 Opko Health Inc Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and preparation process therefor
ES2396051T3 (es) 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
ITMI20062449A1 (it) * 2006-12-19 2008-06-20 Dipharma Spa Forma cristallina di rabeprazolo sodico
ITMI20071502A1 (it) * 2007-07-25 2009-01-26 Archimica Srl Procedimento per la preparazione di formulazioni solide a rilascio controllato contenenti oxcarbazepina e formulazioni ottenibili con tale procedimento
EP2464230B1 (en) * 2009-08-14 2016-10-05 OPKO Health, Inc. Intravenous formulations of rolapitant
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
AU2019348194B2 (en) 2018-09-28 2025-04-03 Griffith University Agents and methods for modulating pathogen activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
FR2700117B1 (fr) 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
IT1272897B (it) 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6670472B2 (en) 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide

Also Published As

Publication number Publication date
DE02718948T1 (de) 2004-07-08
WO2002064557A9 (en) 2002-11-28
ES2211373T1 (es) 2004-07-16
US7183272B2 (en) 2007-02-27
WO2002064557A2 (en) 2002-08-22
IL157351A0 (en) 2004-02-19
HUP0303154A3 (en) 2009-08-28
JP2004526706A (ja) 2004-09-02
CA2437402A1 (en) 2002-08-22
EP1368322A4 (en) 2004-03-17
AU2002250057A1 (en) 2002-08-28
EP1368322A2 (en) 2003-12-10
WO2002064557A3 (en) 2002-10-24
HUP0303154A2 (hu) 2004-01-28
US20030004154A1 (en) 2003-01-02

Similar Documents

Publication Publication Date Title
ID28779A (id) BENTUK-BENTUK KRISTAL DARI EtO2C-CH2-(R)CgL-Aze-Pab-OH
DK1390377T3 (da) Ny krystalform af azithromycin
ID25660A (id) Teripatide kristal
ID25534A (id) Glucagon-seperti kristal peptida-1
DE60227300D1 (de) Strukturen von anschlusselementen und anzuschliessende komponente
DE60223735D1 (de) Interferometer und zugehöriges Herstellungsverfahren
DE60221847D1 (de) Schlaufenmaterialien für klettverschlüsse
NO20022087L (no) Fremgangsmåte for behandling av diabetes
DE50212455D1 (de) Verwendung von Dimerdiolen
NO983632L (no) Krystallform av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid
ATE297920T1 (de) Linezolid-krystall form ii
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
DE10196531T1 (de) Beschleunigungssensor und Herstellungsverfahren dafür
DE60211082D1 (de) Toner und Tonerherstellungsverfahren
DE60135932D1 (de) Farbumsetzeinrichtung und farbumsetzverfahren
DE60210535D1 (de) Vibrator und Herstellungsverfahren desselben
DK1399424T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
NO20041850L (no) Fremgangsmate for dannelse av profenkrystaller
DE50003755D1 (de) Satz von schmuckstücken
IL157351A0 (en) New crystal forms of oxcarbazepine and processes for their preparation
ID21014A (id) Modifikasi kristal dari zat farmasi
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
DK1102747T3 (da) Krystalformer af osenetant
ID20498A (id) Cairan kristal untuk alat penggerak
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi